{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:39:11Z","timestamp":1776357551590,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.metop.2021.100145","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T11:28:53Z","timestamp":1635593333000},"page":"100145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Serious complications of COVID-19 vaccines: A mini-review"],"prefix":"10.1016","volume":"12","author":[{"given":"Paraskevi C.","family":"Fragkou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-263X","authenticated-orcid":false,"given":"Dimitra","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2021.100145_bib3","series-title":"EMA recommends first COVID-19 vaccine for authorisation in the EU","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib4","series-title":"Different COVID-19 vaccines","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib6","series-title":"Status of COVID-19 vaccines within WHO EUL\/PQ evaluation process manufacturer","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib9","doi-asserted-by":"crossref","first-page":"100124","DOI":"10.1016\/j.metop.2021.100124","article-title":"COVID-19 vaccines: current evidence and considerations","volume":"12","author":"Tavilani","year":"2021","journal-title":"Metabolism Open"},{"key":"10.1016\/j.metop.2021.100145_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"The World Allergy Organization Journal"},{"key":"10.1016\/j.metop.2021.100145_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis After receipt of the first dose of pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020","volume":"70","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.metop.2021.100145_bib12","first-page":"680","article-title":"Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine \u2014 United States, March\u2013april 2021","volume":"70","author":"Shay","year":"2021","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.metop.2021.100145_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis After receipt of the first dose of Moderna COVID-19 vaccine \u2014 United States, December 21, 2020\u2013January 10, 2021","volume":"70","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.metop.2021.100145_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE Assessment, and international consensus approach","volume":"9","author":"Greenhawt","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology In Practice"},{"key":"10.1016\/j.metop.2021.100145_bib15","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.vaccine.2020.02.046","article-title":"Immunization stress-related response - redefining immunization anxiety-related reaction as an adverse event following immunization","volume":"38","author":"Gold","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.metop.2021.100145_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organization Journal"},{"key":"10.1016\/j.metop.2021.100145_bib18","series-title":"Management of anaphylaxis at COVID-19 vaccination sites","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib20","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib23","article-title":"Meta-Analysis of risk of vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1-S recombinant vaccine","author":"Chan","year":"2021","journal-title":"Medrvix"},{"key":"10.1016\/j.metop.2021.100145_bib24","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib25","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine\u2013induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib28","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.metop.2021.100101","article-title":"Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story","volume":"11","author":"Tsilingiris","year":"2021","journal-title":"Metabolism Open"},{"key":"10.1016\/j.metop.2021.100145_bib29","volume":"vol. 596","author":"Huynh","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib30","series-title":"Coronavirus (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT)","author":"Aleem","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/children8070607","article-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?","volume":"8","author":"Das","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.metop.2021.100145_bib32","doi-asserted-by":"crossref","first-page":"100102","DOI":"10.1016\/j.metop.2021.100102","article-title":"Major cardiac concerns in therapy and vaccinations for COVID-19","volume":"11","author":"Junapudi","year":"2021","journal-title":"Metabolism Open"},{"key":"10.1016\/j.metop.2021.100145_bib33","series-title":"Selected adverse events reported after COVID-19 vaccination","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib34","series-title":"ACIP June 2021 presentation slides | immunization practices","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.metop.2021.100145_bib37","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1111\/ene.14860","article-title":"Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: a systematic review and meta-analysis","volume":"28","author":"Palaiodimou","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.metop.2021.100145_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.metop.2021.100145_bib39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the advisory committee on immunization practices - United States","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.metop.2021.100145_bib40","series-title":"COVID-19 vaccine safety update VAXZEVRIA AstraZeneca AB","year":"2021"},{"key":"10.1016\/j.metop.2021.100145_bib41","doi-asserted-by":"crossref","first-page":"577691","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature","volume":"359","author":"Min","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.metop.2021.100145_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine","author":"Trimboli","year":"2021","journal-title":"Neurol Sci\u202f: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"key":"10.1016\/j.metop.2021.100145_bib43","article-title":"Neurological complications of COVID-19: guillain-Barre syndrome following pfizer COVID-19 vaccine","volume":"13","author":"Waheed","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.metop.2021.100145_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","article-title":"Oxford-AstraZeneca COVID-19 vaccine efficacy","volume":"397","author":"Knoll","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.metop.2021.100145_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s13760-021-01699-x","article-title":"Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine","volume":"121","author":"Ozgen Kenangil","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.metop.2021.100145_bib46","first-page":"358","article-title":"A case of longitudinally extensive transverse myelitis following vaccination against Covid-19","author":"Pagenkopf","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.metop.2021.100145_bib47","doi-asserted-by":"crossref","first-page":"106839","DOI":"10.1016\/j.clineuro.2021.106839","article-title":"Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination","volume":"208","author":"Vogrig","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.metop.2021.100145_bib48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib49","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2021.100145_bib50","article-title":"Bell\u2019s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine","volume":"13","author":"Iftikhar","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.metop.2021.100145_bib51","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.metop.2021.100145_bib52","doi-asserted-by":"crossref","first-page":"102170","DOI":"10.1016\/j.dsx.2021.06.007","article-title":"COVID-19 vaccine induced rhabdomyolysis: case report with literature review","volume":"15","author":"Nassar","year":"2021","journal-title":"Diabetes & Metabolic Syndrome"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:55:01Z","timestamp":1762905301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936821000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"alternative-id":["S2589936821000694"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2021.100145","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious complications of COVID-19 vaccines: A mini-review","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2021.100145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100145"}}